TrialPanorama/TrialPanorama-database huggingface dataset:
Study NCT00239369 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04009967 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT02823912 — Predictive Biomarker (PRD): MIP mRNA
Genes: MIP; AQP0
Study NCT02823912 — Predictive Biomarker (PRD): TRPV1 mRNA
Genes: TRPV1; VR1
Study NCT02823912 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Free fatty acids
Study NCT01941251 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study NCT01941251 — Safety Biomarker (SAF): BDNF
Study NCT00038311 — Predictive Biomarker (PRD): TPO mRNA
Genes: TPO
Study NCT02901301 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT01826045 — Surrogate Endpoint (SUR): Cervical intraepithelial neoplasia
Study NCT01916577 — Predictive Biomarker (PRD): KIT
Genes: CD117; SCFR; C-Kit
Study NCT03456492 — Surrogate Endpoint (SUR): Serum sodium
Study NCT01664026 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01664026 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT05849792 — Safety Biomarker (SAF): BDNF
Study NCT02458456 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04068584 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00460928 — Predictive Biomarker (PRD): SSB mRNA
Genes: SSB
Study NCT00811200 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT03334565 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01223196 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT01223196 — Predictive Biomarker (PRD): ADAM17 mRNA
Genes: ADAM17; CSVP; TACE
Study NCT01223196 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT01223196 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Intercellular adhesion molecule 1
Genes: ICAM1
Study NCT01223196 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Endothelin-1
Genes: EDN1
Study NCT01223196 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT04146220 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Complement C3
Genes: C3; CPAMD1
Study NCT04146220 — Predictive Biomarker (PRD): CYCS mRNA
Genes: CYCS; CYC
Study NCT04146220 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT00824421 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT04412161 — Predictive Biomarker (PRD): AFP mRNA
Genes: AFP; HPAFP
Study NCT04412161 — Predictive Biomarker (PRD): GGT1 mRNA
Genes: GGT1; GGT
Study NCT05450575 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02048397 — Predictive Biomarker (PRD): GPR55 mRNA
Genes: GPR55
Study NCT02048397 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT02048397 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT02048397 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT02048397 — Pharmacodynamic Biomarker (PDY): Superoxide dismutase Cu-Zn
Genes: SOD1
Study NCT04273152 — Predictive Biomarker (PRD): AGER mRNA
Genes: AGER; RAGE
Study NCT03738956 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT03738956 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT03738956 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT03738956 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study NCT03877406 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study NCT02888769 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03291028 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT01186432 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study NCT02448628 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00683150 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02756364 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT03593187 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study NCT03593187 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT04677452 — Predictive Biomarker (PRD): TNFRSF17 mRNA
Genes: TNFRSF17; BCM; BCMA
Study NCT01777425 — Predictive Biomarker (PRD): AR mRNA
Genes: AR; DHTR; NR3C4
Study NCT04556669 — Predictive Biomarker (PRD): CD22 mRNA
Genes: CD22; SIGLEC2
Study NCT03701503 — Predictive Biomarker (PRD): PYY mRNA
Genes: PYY
Study NCT00002571 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT02277821 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04771715 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT02005900 — Predictive Biomarker (PRD): PPARA mRNA
Genes: PPARA; NR1C1; PPAR
Study NCT02005900 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT01399489 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01584778 — Safety Biomarker (SAF): Eosinophil cationic protein
Genes: RNASE3; ECP; RNS3
Study NCT03919240 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT01509027 — Pharmacodynamic Biomarker (PDY): Serum phosphate
Study NCT03816605 — Pharmacodynamic Biomarker (PDY): Fibroblast growth factor 19
Genes: FGF19; UNQ334/PRO533
Study NCT03816605 — Pharmacodynamic Biomarker (PDY): Insulin receptor substrate 1
Genes: IRS1
Study NCT00248066 — Predictive Biomarker (PRD): MYC mRNA
Genes: MYC; BHLHE39
Study NCT02508415 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT03053349 — Predictive Biomarker (PRD): PVR mRNA
Genes: PVR; PVS
Study NCT03053349 — Predictive Biomarker (PRD): PIP mRNA
Genes: PIP; GCDFP15; GPIP4
Study NCT03053349 — Surrogate Endpoint (SUR): Pulmonary vascular resistance
Study NCT01575912 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00840463 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study NCT00840463 — Surrogate Endpoint (SUR): Pulmonary vascular resistance
Study NCT02372435 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT01649492 — Predictive Biomarker (PRD): CYP2C9 mRNA
Genes: CYP2C9; CYP2C10
Study NCT03843346 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT00738725 — Predictive Biomarker (PRD): SLC25A20 mRNA
Genes: SLC25A20; CAC; CACT
Study NCT03932955 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT03016234 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04787510 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT03405103 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT03623750 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT03623750 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT05237544 — Pharmacodynamic Biomarker (PDY): Survival motor neuron protein
Genes: SMN1; SMN; SMNT;; SMN2; SMNC
Study NCT02509793 — Pharmacodynamic Biomarker (PDY): Huntingtin
Genes: HTT; HD; IT15
Study NCT03326232 — Monitoring Biomarker (MOI): Adenosine deaminase
Genes: ADA; ADA1
Study NCT01741116 — Pharmacodynamic Biomarker (PDY): Fibroblast growth factor 23
Genes: FGF23; HYPF; UNQ3027/PRO9828
Study NCT00925821 — Safety Biomarker (SAF): Beta-2-microglobulin
Genes: B2M; CDABP0092; HDCMA22P
Study NCT02192853 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study NCT04194931 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT04194931 — Predictive Biomarker (PRD): TNFRSF17 mRNA
Genes: TNFRSF17; BCM; BCMA
Study NCT00791492 — Predictive Biomarker (PRD): TTR mRNA
Genes: TTR; PALB
Study NCT01702922 — Predictive Biomarker (PRD): NF1 mRNA
Genes: NF1
Study NCT04458337 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT02162303 — Predictive Biomarker (PRD): PAFAH1B1 mRNA
Genes: PAFAH1B1; LIS1; MDCR; MDS; PAFAHA
Study NCT00077779 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT00150384 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05069779 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00561691 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT01026610 — Monitoring Biomarker (MOI): HBV DNA
Study NCT00049634 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT03885999 — Predictive Biomarker (PRD): LARS1 mRNA
Genes: LARS1; KIAA1352; LARS
Study NCT02838472 — Predictive Biomarker (PRD): NNT mRNA
Genes: NNT
Study NCT02838472 — Safety Biomarker (SAF): Reactive oxygen species
Study NCT00396383 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study NCT03974984 — Safety Biomarker (SAF): Neutrophil to lymphocyte
Study NCT04106596 — Predictive Biomarker (PRD): LGI1 mRNA
Genes: LGI1; EPT; UNQ775/PRO1569
Study NCT04106596 — Predictive Biomarker (PRD): GAD1 mRNA
Genes: GAD1; GAD; GAD67
Study NCT02427373 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study NCT00001341 — Predictive Biomarker (PRD): Thymidylate synthase 
Genes: TYMS; TS; OK/SW-cl.29
Study NCT01949688 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HLA-A
Study NCT04271163 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Microtubule-associated protein tau
Genes: MAPT; MAPTL; MTBT1; TAU
Study NCT04103034 — Safety Biomarker (SAF): von Willebrand factor
Genes: VWF; F8VWF
Study NCT00533520 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study NCT00608140 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04992871 — Predictive Biomarker (PRD): CP mRNA
Genes: CP
Study NCT04438421 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT00003102 — Predictive Biomarker (PRD): Carbonic anhydrase IX
Genes: CA9; G250; MN
Study NCT02874963 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT04366726 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT02479464 — Predictive Biomarker (PRD): 5HTT
Genes: SLC6A4; 5-HTT; SERT1
Study NCT02479464 — Safety Biomarker (SAF): Cytochrome P450 2D6
Genes: CYP2D6; CYP2DL1
Study NCT02479464 — Safety Biomarker (SAF): Cytochrome P450 2C19
Genes: CYP2C19
Study NCT03666884 — Predictive Biomarker (PRD); Safety Biomarker (SAF): DES mRNA
Genes: DES
Study NCT00366379 — Predictive Biomarker (PRD): GK mRNA
Genes: GK
Study NCT02242396 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02947750 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00571025 — Predictive Biomarker (PRD): Apolipoprotein E
Genes: APOE
Study NCT03740100 — Predictive Biomarker (PRD): NOTCH1 mRNA
Genes: NOTCH1; TAN1
Study NCT03740100 — Predictive Biomarker (PRD); Safety Biomarker (SAF): PIK3CA
Genes: PI3K
Study NCT03611101 — Predictive Biomarker (PRD): FGF21 mRNA
Genes: FGF21; UNQ3115/PRO10196
Study NCT01405079 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT01405079 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT02340156 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Cellular tumor antigen p53
Genes: TP53; P53
Study NCT00046566 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04252378 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02447510 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT03035812 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00511654 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study NCT04236310 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT03968003 — Predictive Biomarker (PRD): PYY mRNA
Genes: PYY
Study NCT03968003 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT03968003 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT03047382 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT03333538 — Surrogate Endpoint (SUR): Neutralizing antibody response
Study NCT03333538 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT04295460 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT02870764 — Predictive Biomarker (PRD): PLA2G1B mRNA
Genes: PLA2G1B; PLA2; PLA2A; PPLA2
Study NCT04104711 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03716102 — Predictive Biomarker (PRD); Safety Biomarker (SAF): DES mRNA
Genes: DES
Study NCT03806894 — Predictive Biomarker (PRD): VASP mRNA
Genes: VASP
Study NCT00001756 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study NCT00001756 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT00001756 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT01350388 — Surrogate Endpoint (SUR): Serum uric acid
Study NCT02449603 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT03989115 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT02238977 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT01813487 — Monitoring Biomarker (MOI): HBV DNA
Study NCT01750918 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT03037905 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00266162 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study NCT00266162 — Surrogate Endpoint (SUR): Pulmonary vascular resistance
Study NCT04303468 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02814617 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT03011463 — Predictive Biomarker (PRD): SLC22A1 mRNA
Genes: SLC22A1; OCT1
Study NCT03661216 — Surrogate Endpoint (SUR): Urinary oxalate
Study NCT00743678 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT04502784 — Pharmacodynamic Biomarker (PDY): Fibroblast growth factor 23
Genes: FGF23; HYPF; UNQ3027/PRO9828
Study NCT03937154 — Predictive Biomarker (PRD): TPO mRNA
Genes: TPO
Study NCT03767569 — Surrogate Endpoint (SUR): Serum testosterone
Study NCT02964078 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT02964078 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT04046822 — Predictive Biomarker (PRD): NPY mRNA
Genes: NPY
Study NCT03497767 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT02621333 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT00291629 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT00291629 — Predictive Biomarker (PRD); Safety Biomarker (SAF): DES mRNA
Genes: DES
Study NCT00661453 — Pharmacodynamic Biomarker (PDY): Survival motor neuron protein
Genes: SMN1; SMN; SMNT;; SMN2; SMNC
Study NCT00661453 — Pharmacodynamic Biomarker (PDY): Valproic acid
Study NCT02362425 — Predictive Biomarker (PRD): RYR1 mRNA
Genes: RYR1; RYDR
Study NCT04468113 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04468113 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT04395157 — Pharmacodynamic Biomarker (PDY): Mismatch negativity
Study NCT03510221 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02304354 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT02304354 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT02354001 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT00951795 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT04490057 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT00116415 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT00116415 — Surrogate Endpoint (SUR): Undetectable plasma HIV RNA
Study NCT03554239 — Safety Biomarker (SAF): Cytochrome P450 2C19
Genes: CYP2C19
Study NCT01769521 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00055497 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT02461459 — Predictive Biomarker (PRD): ID1 mRNA
Genes: ID1; BHLHB24; ID
Study NCT02461459 — Predictive Biomarker (PRD): SLC12A3 mRNA
Genes: SLC12A3; NCC; TSC
Study NCT03742739 — Predictive Biomarker (PRD): IVL mRNA
Genes: IVL
Study NCT04670757 — Predictive Biomarker (PRD): JAK1 mRNA
Genes: JAK1; JAK1A; JAK1B
Study NCT04670757 — Predictive Biomarker (PRD): JAK3 mRNA
Genes: JAK3
Study NCT04670757 — Predictive Biomarker (PRD): JAK2 mRNA
Genes: JAK2
Study NCT00618956 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02257632 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT00713570 — Predictive Biomarker (PRD): COMT mRNA
Genes: COMT
Study NCT00713570 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study NCT03813641 — Predictive Biomarker (PRD): Thymidylate synthase 
Genes: TYMS; TS; OK/SW-cl.29
Study NCT04399538 — Surrogate Endpoint (SUR): Serum triglycerides
Study NCT02411344 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT02411344 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT04371510 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT00524303 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT01823588 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03715543 — Predictive Biomarker (PRD): GSN mRNA
Genes: GSN
Study NCT04612088 — Surrogate Endpoint (SUR): Serum calcium
Study NCT00253097 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04438564 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT03581617 — Predictive Biomarker (PRD): LILRB1 mRNA
Genes: LILRB1; ILT2; LIR1; MIR7
Study NCT03581617 — Predictive Biomarker (PRD): KLRC1 mRNA
Genes: KLRC1; NKG2A
Study NCT01490398 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT02242370 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02493530 — Predictive Biomarker (PRD); Safety Biomarker (SAF): PIK3CA
Genes: PI3K
Study NCT04183569 — Predictive Biomarker (PRD): RAB11FIP1 mRNA
Genes: RAB11FIP1; RCP
Study NCT01441245 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study NCT03191786 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study NCT03019055 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT03095937 — Predictive Biomarker (PRD): RHD mRNA
Genes: RHD
Study NCT03160144 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT03160144 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT00051844 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT00659672 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04410341 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study NCT03931837 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02638181 — Predictive Biomarker (PRD): MMP13 mRNA
Genes: MMP13
Study NCT01670461 — Predictive Biomarker (PRD): FANCE mRNA
Genes: FANCE; FACE
Study NCT01336426 — Predictive Biomarker (PRD): PADI1 mRNA
Genes: PADI1; PAD1; PDI1
Study NCT02857712 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT01984905 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Metalloproteinase inhibitor 1
Genes: TIMP1; CLGI; TIMP
Study NCT04025125 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04600999 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT02856893 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT00964080 — Predictive Biomarker (PRD): MBP mRNA
Genes: MBP
Study NCT02298244 — Surrogate Endpoint (SUR): Pulmonary vascular resistance
Study NCT02914626 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT02914626 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT02514473 — Predictive Biomarker (PRD): CFTR mRNA
Genes: CFTR; ABCC7
Study NCT02514473 — Predictive Biomarker (PRD): CFTR
Genes: MRP7; ABC35; TNR-CFTR; dJ760C5.1; CFTR/MRP
Study NCT05081674 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT05081674 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study NCT05081674 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT01110551 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT00201370 — Surrogate Endpoint (SUR): Cervical intraepithelial neoplasia
Study NCT00609362 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT01525901 — Predictive Biomarker (PRD): SHANK3 mRNA
Genes: SHANK3; KIAA1650; PROSAP2; PSAP2
Study NCT04449029 — Monitoring Biomarker (MOI): HBV DNA
Study NCT02360098 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03433027 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1